John Huynh is the Chief Technology Officer at IconOVir Bio. He joins IconOVir from Ring Therapeutics, where he served as Senior Vice President of Technical Operations and was responsible for overseeing CMC development and manufacturing. Prior to joining Ring, he was a Vice President of Gene Therapy Technical Operations at PTC Therapeutics, where he helped establish and grow their gene therapy CMC group and made significant contributions to enable the marketing authorization of Upstaza, only the fourth in vivo gene therapy ever approved. Before that, John held positions of increasing responsibilities at Merck, WuXi AppTec, and the University of Pennsylvania Gene Therapy Program, focusing his career on process development and life-cycle management of viral vaccines and vectors.
John holds a Ph.D. in Biomedical Engineering from Cornell University and a B.S. in Biomedical Engineering from the University of Texas at Austin.